Atrial Fibrillation Also called: AF, Afib

Clinical Trial Finder

Many patients with atrial fibrillation are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Clinical Relevance of Microbleeds In Stroke

Conditions:   Stroke;   Atrial Fibrillation (AF);   Intracerebral Haemorrhage (ICH)
Intervention:  
Sponsor:   University College, London
Recruiting - verified July 2015

Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function

Conditions:   Persistent Atrial Fibrillation;   Congestive Heart Failure Due to Left Ventricular Systolic Dysfunction
Interventions:   Procedure: Atrial fibrillation catheter ablation;   Procedure: Rate control
Sponsors:   University of Turin, Italy;   Centro Cardiologico Monzino;   Humanitas Research Hospital IRCCS, Rozzano-Milan;   University of Padua;   Policlinico Casilino ASL RMB
Not yet recruiting - verified July 2015

Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Drug: rosuvastatin
Sponsor:   The Third Xiangya Hospital of Central South University
Not yet recruiting - verified July 2015

mHealth Screening to Prevent Strokes

Condition:   Atrial Fibrillation
Interventions:   Device: iRhythm ZIO XT Patch;   Device: Wristband by Amiigo
Sponsors:   Scripps Translational Science Institute;   Janssen Scientific Affairs, LLC;   Aetna, Inc.
Not yet recruiting - verified July 2015

ELR Monitoring Against Permanent Pacemaker in Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Device: R test;   Device: Nuubo;   Device: TECHNOMED pocket ECG;   Device: ZIO xt patch;   Device: MoMe
Sponsor:   Eastbourne General Hospital
Not yet recruiting - verified July 2015

Laser Ablation Study for trEatment of atRial Fibrillation (LASER)

Condition:   Atrial Fibrillation
Interventions:   Device: Laser ablation;   Device: RF ablation
Sponsors:   Hospital Clinic of Barcelona;   CardioFocus
Recruiting - verified July 2015

Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Ischemic Stroke;   Transient Ischemic Attack
Interventions:   Device: Single lead ECG device;   Device: 7-Day Holter monitor.
Sponsors:   Leiden University Medical Center;   Medical Center Haaglanden;   Groene Hart Ziekenhuis;   Herning Hospital;   Bronovo Hospital
Not yet recruiting - verified July 2015

Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA

Conditions:   Brain Ischemia With Non-valvular Atrial Fibrillation;   Transient Ischemic Attack With Non-valvular Atrial Fibrillation
Intervention:  
Sponsor:   University Hospital, Essen
Recruiting - verified July 2015

Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: novel oral anticoagulant for 30 days;   Drug: novel oral anticoagulant for 24 hour
Sponsor:   Yonsei University
Recruiting - verified July 2015

A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care

Conditions:   Pain;   Chronic Pain;   Mental Disorders;   Cardiovascular Diseases;   Diabetes Mellitus, Type 2;   Arthritis
Interventions:   Other: Unblinded to Genetic Testing Results;   Other: Blinded to Genetic Testing Results
Sponsor:   Proove Bioscience, Inc.
Recruiting - verified July 2015

Study of ACP-196 Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

Condition:   Chronic Lymphocytic Leukemia
Interventions:   Drug: ACP-196;   Drug: ibrutinib
Sponsor:   Acerta Pharma BV
Recruiting - verified July 2015

WATCHMAN Implantation During Hybrid Ablation

Conditions:   Atrial Fibrillation;   Stroke
Intervention:   Device: WATCHMAN Device implantation
Sponsors:   Maastricht University Medical Center;   Boston Scientific Corporation
Recruiting - verified July 2015

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Condition:   Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke
Intervention:  
Sponsor:   Bristol-Myers Squibb
Recruiting - verified July 2015

Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Medtronic Atrial Fibrillation Solutions;   IHF GmbH - Institut für Herzinfarktforschung
Recruiting - verified July 2015

SMART-SF Radiofrequency Ablation Safety Study

Condition:   Atrial Fibrillation
Intervention:   Device: THERMOCOOL® SMARTTOUCH® (RF ablation treatment)
Sponsor:   Biosense Webster, Inc.
Recruiting - verified July 2015

Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter

Conditions:   Atrial Fibrillation;   Stroke
Intervention:   Other: Computer Electronic Alert
Sponsors:   Brigham and Women's Hospital;   Daiichi Sankyo Inc.
Not yet recruiting - verified July 2015

CCC Project - Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Beijing Institute of Heart, Lung and Blood Vessel Diseases;   American Heart Association;   Chinese Society of Cardiology
Recruiting - verified July 2015

FAST Mapping During Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Procedure: FAST mapping and ablation;   Procedure: PVI
Sponsor:   University Health Network, Toronto
Recruiting - verified July 2015

Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study

Condition:   Stroke, Acute
Intervention:  
Sponsors:   University of Zurich;   Swiss National Science Foundation
Recruiting - verified July 2015

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Condition:   Atrial Fibrillation
Interventions:   Drug: Dabigatran etexilate;   Drug: Phenprocoumon
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

Cologne Cardioversion Study

Conditions:   Atrial Arrhythmia;   Heart Failure
Interventions:   Device: Internal Electrocardioversion;   Device: External Electrocardioversion
Sponsors:   Universitätsklinikum Köln ;   Medtronic;   St. Jude Medical
Recruiting - verified July 2015

Safety of External Electrocardioversion in Device Patients

Condition:   Atrial Arrhythmia
Intervention:   Procedure: Cardioversion
Sponsor:   Universitätsklinikum Köln 
Recruiting - verified July 2015

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

Conditions:   Venous Thromboembolism;   Atrial Fibrillation
Intervention:   Other: complications and compliance with GIHP recommendations
Sponsors:   University Hospital, Grenoble;   Floralis
Recruiting - verified July 2015

Atrial Fibrillation, Cardiac Symptoms, and Anxiety

Conditions:   Atrial Fibrillation;   Anxiety
Intervention:   Behavioral: Mindfulness and Interoceptive Exposure
Sponsor:   Brigham and Women's Hospital
Recruiting - verified July 2015

Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure

Condition:   Permanent Atrial Fibrillation
Interventions:   Procedure: AV junction ablation;   Device: CRT;   Drug: Optimized drug therapy;   Device: ICD
Sponsor:   Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella
Recruiting - verified July 2015

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
Sponsors:   Daiichi Sankyo Inc.;   Covance;   Quintiles
Recruiting - verified July 2015

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

Condition:   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
Sponsors:   Pfizer;   Bristol-Myers Squibb
Recruiting - verified July 2015

Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients With Heart Failure and Preserved Ejection Fraction

Condition:   Heart Failure With Preserved Ejection Fraction (HFpEF)
Intervention:   Device: ILR implantation
Sponsors:   University Medical Centre Groningen;   St. Jude Medical
Recruiting - verified July 2015

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Conditions:   Rivaroxaban;   Cancer-associated Thrombosis;   Recurrence;   Bleeding
Intervention:   Drug: Rivaroxaban
Sponsors:   Seoul National University Hospital;   Korean Society of Hematology Thrombosis Working Party
Recruiting - verified July 2015

Pacing in First-degree AV-block

Conditions:   First-degree AV-block;   Pacing
Intervention:   Other: Pacing
Sponsors:   Duke University;   Medtronic
Not yet recruiting - verified February 2015

Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation

Condition:   Persistent Atrial Fibrillation
Interventions:   Device: HeartLight(TM) Laser Balloon;   Device: irrigated radiofrequency current ablation
Sponsor:   Boris Schmidt
Recruiting - verified July 2015

Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery

Conditions:   Vascular Death;   Myocardial Infarction;   Stroke;   Cardiac Surgery
Intervention:  
Sponsors:   Population Health Research Institute;   Abbott Diagnostics Division
Recruiting - verified July 2015

SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea

Condition:   Atrial Fibrillation
Intervention:   Drug: Pradaxa (Dabigatran etexilate mesilate)
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation

Condition:   Atrial Fibrillation
Intervention:   Drug: Adenosine arm
Sponsor:   Medical College of Wisconsin
Completed - verified July 2015

Risk Profile for Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   University Medical Centre Groningen
Completed - verified July 2015

Risk Profile for Patients With Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   I.C. Van Gelder;   Netherlands Heart Foundation
Recruiting - verified July 2015

Markers of Paroxysmal Atrial Fibrillation in Esophageal Holter Electrocardiography

Conditions:   Atrial Fibrillation;   Atrial Premature Complexes
Intervention:  
Sponsors:   University Hospital Inselspital, Berne;   Commission for Technology and Innovation of the Swiss Federal Administration
Completed - verified July 2015

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery

Condition:   Atrial Fibrillation
Interventions:   Drug: Amiodarone;   Drug: Minocycline
Sponsor:   Baystate Medical Center
Active, not recruiting - verified July 2015

Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure

Condition:   Atrial Fibrillation
Interventions:   Other: Upstream therapy;   Other: Conventional rhythm control
Sponsors:   I.C. Van Gelder;   The Interuniversity Cardiology Institute of the Netherlands;   Netherlands Heart Foundation;   Dutch Network for Cardiovascular Research;   Trial Coordination Center UMC Groningen;   Bayer;   Boehringer Ingelheim;   Medtronic;   Biotronik SE & Co. KG;   St. Jude Medical;   Boston Scientific Corporation;   AstraZeneca
Recruiting - verified July 2015

Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter

Conditions:   Atrial Fibrillation;   Atrial Flutter
Interventions:   Drug: Ramipril;   Drug: Placebo
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Sanofi;   Ministry of Health, France;   Sorin Group
Terminated - verified July 2015

Get CardioSmart

You're Invited

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points